These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7926148)

  • 21. Different influence of incongruent follicular development on in vitro fertilization-embryo transfer and gamete intrafallopian transfer pregnancy rates.
    Eldar-Geva T; Lowe PJ; MacLachlan V; Rombauts L; Healy DL
    Fertil Steril; 1998 Dec; 70(6):1039-43. PubMed ID: 9848292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IVF and related technology. The present and the future.
    Trounson AO; Wood C
    Med J Aust; 1993 Jun; 158(12):853-7. PubMed ID: 8326900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Success rates with gamete intrafallopian transfer and in vitro fertilization in women of advanced maternal age.
    Bopp BL; Alper MM; Thompson IE; Mortola J
    Fertil Steril; 1995 Jun; 63(6):1278-83. PubMed ID: 7750601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
    Lind T; Holte J; Olofsson JI; Hadziosmanovic N; Gudmundsson J; Nedstrand E; Lood M; Berglund L; Rodriguez-Wallberg K
    Hum Reprod; 2018 Feb; 33(2):238-247. PubMed ID: 29211889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural cycle in vitro fertilization-embryo transfer at the University of Ottawa: an inefficient therapy for tubal infertility.
    Claman P; Domingo M; Garner P; Leader A; Spence JE
    Fertil Steril; 1993 Aug; 60(2):298-302. PubMed ID: 8339827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the antral follicle count to predict the outcome of assisted reproductive technologies.
    Chang MY; Chiang CH; Hsieh TT; Soong YK; Hsu KH
    Fertil Steril; 1998 Mar; 69(3):505-10. PubMed ID: 9531887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
    Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
    Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization.
    Urbancsek J; Witthaus E
    Fertil Steril; 1996 May; 65(5):966-71. PubMed ID: 8612858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study.
    Weigert M; Krischker U; Pöhl M; Poschalko G; Kindermann C; Feichtinger W
    Fertil Steril; 2002 Jul; 78(1):34-9. PubMed ID: 12095487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of concurrent pregnancy rates for in-vitro fertilization--embryo transfer, pronuclear stage embryo transfer and gamete intra-fallopian transfer.
    Hammitt DG; Syrop CH; Hahn SJ; Walker DL; Butkowski CR; Donovan JF
    Hum Reprod; 1990 Nov; 5(8):947-54. PubMed ID: 2081806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conception rate after in vitro fertilization in patients who conceived in a previous cycle.
    Simon A; Ronit C; Lewin A; Mordel N; Zajicek G; Laufer N
    Fertil Steril; 1993 Feb; 59(2):343-7. PubMed ID: 8425629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction.
    Wikland M; Borg J; Hamberger L; Svalander P
    Hum Reprod; 1994 Aug; 9(8):1430-6. PubMed ID: 7989500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective comparative study on IVF outcomes with either purified FSH or human menopausal gonadotrophin in downregulated normogonadotrophic women.
    Ismail AF; Hesham AI; Salah Z; Khaled M; Fouad N; Ashraf N; Hatem S; Hamdi B
    Gynecol Obstet Invest; 2002; 53(4):220-3. PubMed ID: 12186987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pregnancy rates of cohorts of idiopathic infertility couples gives insights into the underlying mechanism of infertility.
    Martin JS; Nisker JA; Parker JI; Kaplan B; Tummon IS; Yuzpe AA
    Fertil Steril; 1995 Jul; 64(1):98-102. PubMed ID: 7789587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of delayed suppression using buserelin acetate and recombinant follicle-stimulating hormone in a long protocol in vitro fertilization program.
    Ravhon A; Aurell R; Lawrie H; Margara R; Winston RM
    Fertil Steril; 2000 Feb; 73(2):325-9. PubMed ID: 10685537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer.
    Moon HS; Park SH; Lee JO; Kim KS; Joo BS
    Fertil Steril; 2004 Oct; 82(4):816-20. PubMed ID: 15482753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.